Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma-Reference-Cited by-同舟云学术

Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma

Published:2023-02 Issue: Volume:169 Page:164-171
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Ackroyd Sarah A.,Arguello David,Ramos Pilar,Mahdi Haider,ElNaggar Adam,Winer Ira,Holloway Rob,Krivak Thomas,Jones Nathaniel,Turner Valerie Galvan,Herzog Thomas,Chu Christina,Brown Jubilee,Mantia-Smaldone Gina

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference39 articles.

1. Clear cell carcinoma of the ovary: a review of the literature;del Carmen;Gynecol. Oncol.,2012

2. Prognostic implication of endometriosis in clear cell carcinoma of the ovary;Orezzoli;Gynecol. Oncol.,2008

3. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers;Chan;Gynecol. Oncol.,2008

4. Prognostic factors for stage III epithelial ovarian cancer: a gynecologic oncology group study;Winter;J. Clin. Oncol.,2007

5. Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease;Goff;Gynecol. Oncol.,1996

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aberrant SWI/SNF Complex Members Are Predominant in Rare Ovarian Malignancies—Therapeutic Vulnerabilities in Treatment-Resistant Subtypes;Cancers;2024-09-03

2. Sintilimab combined with bevacizumab in relapsed or persistent ovarian clear cell carcinoma (INOVA): a multicentre, single-arm, phase 2 trial;The Lancet Oncology;2024-09

3. Lipid droplets: a candidate new research field for epithelial ovarian cancer;Frontiers in Pharmacology;2024-07-01

4. Endometriosis-Associated Ovarian Cancer: From Molecular Pathologies to Clinical Relevance;International Journal of Molecular Sciences;2024-04-13

5. ARID1A deficiency associated with MMR deficiency and a high abundance of tumor-infiltrating lymphocytes predicts a good prognosis of endometrial carcinoma;Translational Oncology;2023-07